Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-07

The role of transcription factor, ets2, in inhibiting programmed cell death - apoptosis

Objective



Research objectives and content
Ets2 is a transcription factor regulating the expression of genes involved in cell growth, differentiation and developmental processes. Unpublished results from Dr. Boulukos' laboratory show that Ets2 can also inhibit programmed cell death (apoptosis). This is the first observation indicating that Ets2 can play a role in controlling cell death processes. They observe that while macrophages die by apoptosis in the absence of macrophage colony stimulating factor (CSF-1), a factor necessary for the growth and survival of myeloid cells, macrophages constitutively expressing Ets2 survive under the same conditions. I propose to investigate whether this inhibition of programmed cell death by Ets2 is a general phenomenon. Two different cellular systems available in the laboratory will be used to address this question. I will develop a third cellular system where Ets2 expression will be inducible. This system will be used to determine at what point(s) Ets2 expression is necessary to inhibit the initiation of the cell death program. Finally, I will investigate the mechanism of inhibition of apoptosis by Ets2. Several genes are implicated in controlling cell death. I am interested in determining whether one or several of these genes are direct downstream targets of Ets2.
Training content (objective, benefit and expected impact)
I chose Dr. Boulukos' laboratory because I want to obtain in experience in a new and exciting field of research. My objectives are to learn about a transcription factor which not only induces macrophage differentiation, but also controls the cell death program. I will clearly benefit by learning the current techniques used in molecular and cell biology including cloning, sequencing, Northern and Western analyses, cell transfections, gel retardation assays, transcription activation assays and
immunofluorescence studies. Dr. Boulukos' laboratory has both the equipment and experience to provide an excellent scientific environment for my training as a post doctoral fellow. The impact of this work is of great importance especially considering that deregulating Ets2 expression can result in certain types of leukemias.
Links with industry / industrial relevance (22)

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

RGI - Research grants (individual fellowships)

Coordinator

Institut National de la Santé et de la Recherche Médicale
EU contribution
No data
Address
Université de Nice, Parc Valrose
06108 Nice
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (1)

My booklet 0 0